Section 1: The Economics Nobody Talks About Generic drugs fill roughly 90% of all U.S. prescriptions while accounting for only […]

A deep-dive for pharma IP teams, portfolio managers, R&D leads, and institutional investors Executive Summary The generic pharmaceutical industry is

Defining a Blockbuster Drug in 2026 — and Why the Definition Is Shifting The pharmaceutical industry has operated with a

A deep dive into patent cliffs, IP valuation, biosimilar development roadmaps, complex generics portfolios, and the regulatory playbooks that will

Part I: The Economics of Generic Entry — Why the Old Model Is Broken The Scale of the Industry and

Key Facts Before You Read Part I: The Market Paradox and Its Structural Drivers The Affordability Paradox: Why the Generic

The generic pharmaceutical market saves the U.S. healthcare system approximately $445 billion a year. Generics account for 90% of all

Every blockbuster drug is, at its core, a time-limited monopoly. The moment that monopoly expires, the revenue collapses. Pfizer watched

The U.S. generic drug market saved the healthcare system $445 billion in 2023 alone. Generics fill 90% of all prescriptions